Diabetes News and Research

Latest Diabetes News and Research

New $13.75M data-mining project to better understand factors behind mental disorders

Chicago will be home to a new $13.75 million project that will apply data mining methods to better understand the genetic and environmental factors behind neuropsychiatric disorders.

7 Oct 2011

Global efforts must be coordinated immediately to prevent, control NCDs

In this Scientist opinion piece, Edward Partridge, president of the American Cancer Society and director of the Comprehensive Cancer Center at the University of Alabama at Birmingham, Elizabeth Mayer-Davis, president of health care and education at the American Diabetes Association, and Ralph Sacco, immediate past president of the American Heart Association/American Stroke Association and professor and chairman of neurology at the Miller School of Medicine at the University of Miami, write that while last month's U.N.

7 Oct 2011

Co-occurrence of medical and psychiatric disease is likely to affect QoL

This review provides evidence of a substantially reduced psychosocial and physical quality of life in medically ill patients with comorbid mental disorders. This patient-reported outcome highlights the importance of recognizing and treating comorbid mental disorders in the medically ill.

7 Oct 2011

Scientists discover rare genetic alteration responsible for hypoglycaemia

Cambridge scientists have identified the cause of a rare, life-threatening form of hypoglycaemia. Their findings, which have the potential to lead to pharmaceutical treatments for the disorder, were published today, 07 October, in the journal Science.

7 Oct 2011

Logistic regression models identify risk factors for open angle glaucoma

Early detection and diagnosis of open angle glaucoma important so that treatment can be used in the early stages of the disease developing to prevent or avoid further vision loss.

7 Oct 2011

Teriflunomide drug reduces relapse rate of people with MS

A new oral drug has been shown in a large international clinical trial to significantly reduce the relapse rate of people with multiple sclerosis and to slow the progression of the disease.

7 Oct 2011

Roundup: Health alliances formed in Calif., Wash.; Mass. group seeks repeal of mandate there

One of Southern California's largest hospital systems is teaming up with hundreds of doctors in a new alliance designed to better manage patient care, improve medical outcomes and reduce costs. Under the partnership with Providence Health & Services of Southern California, doctors will share and analyze data about diabetes, congestive heart failure and other conditions to identify effective practices and eliminate inefficiencies that drive up expenses.

7 Oct 2011

Thriving stem cells created by cloning technique

In a breakthrough that has been debated and awaited for long, scientists have finally derived colonies of embryonic stem cells from human embryos created using cloning technology.

6 Oct 2011

People with good vitamin D supply at lower risk of developing Type 2 diabetes

Scientists at the Helmholtz Zentrum München have shown that people with a good vitamin D supply are at lower risk of developing Type 2 diabetes mellitus. The study, which was conducted in cooperation with the German Diabetes Center and the University of Ulm, will be published in the October edition of the renowned scientific journal Diabetes Care.

4 Oct 2011

First Edition: October 4, 2011

Today's news highlights include reports that the Supreme Court kicked off its new term by hearing a key Medicaid case that tests whether providers and patients can go to court to challenge decisions by cash-strapped states to reduce Medicaid payments.

4 Oct 2011

New NIH grant to continue exploration of Fusobacterium nucleatum-associated Beta-Defensin Inducer

Research from Case Western Reserve University School of Dental Medicine to study an isolated agent from common oral bacteria may hold the answer as to how human beta defensins (HBDs)-nature's way of keeping oral microbes from entering the body and wreaking havoc with our health-can be used to create new treatments to block bacteria from entering through the epithelial linings on and in the body.

4 Oct 2011

New review finds inconsistency in studies that examine link between CCSVI and MS

Studies that examined the possible link between vein blockages and multiple sclerosis are so inconsistent that it's impossible to reach a firm conclusion about the controversial theory, a new review has found.

4 Oct 2011

Stroke more prevalent among Metis than other Manitobans

The stroke rate among Manitoba Metis is nearly 25 percent higher than for other Manitobans, according to a study by the University of Manitoba and the Manitoba Metis Federation (MMF) presented today at the Canadian Stroke Congress.

4 Oct 2011

Researchers identify new enzyme function that may protect against anemia

Researchers at St. Michael's Hospital have discovered a new function for an enzyme that may protect against organ injury and death from anemia.

4 Oct 2011

Men get type 2 diabetes at a lower BMI than women: Study

A latest study reveals that men need to gain little weight in order to develop type 2 diabetes as compared to women. A study carried out by clinical academics at Glasgow University found men developed the disease at a lower Body Mass Index than women, explaining why men have higher rates of diabetes in many parts of the world.

3 Oct 2011

Discovery of ‘alarm-clock’ gene

Researchers led by Indian-American scientist, Satchidananda Panda at the Salk Institute for Biological Studies in La Jolla, Calif., said the gene is responsible for starting the body’s biological clock from its restful state every morning. They add that this may open avenues in research in insomnia or sleeplessness, aging and chronic illnesses.

3 Oct 2011

Despite increase in cases, awareness of male breast cancer is low

Awareness of male breast cancer is low and most men do not even know they are at risk despite an increase in cases, reveals new research from the University of Leeds.

3 Oct 2011

Sangamo's SB-509 fails to meet key endpoints in Phase 2b study for diabetic neuropathy

Sangamo BioSciences, Inc. today announced that its Phase 2b study (SB-509-901) did not meet its primary or secondary clinical endpoints in subjects with moderate severity diabetic neuropathy (DN) as compared to placebo.

3 Oct 2011

Working in shifts associated with elevated levels of stress hormone cortisol

A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) found that shift work at a young age is associated with elevated long-term cortisol levels and increased BMI. Previous studies have shown that long-term elevated cortisol levels lead to increased abdominal obesity, hypertension, diabetes and cardiovascular risk.

3 Oct 2011

Health Canada approves Trajenta (linagliptin) for type 2 diabetes

Boehringer Ingelheim Canada and Eli Lilly Canada today announced that Health Canada has approved Trajenta (linagliptin), a new oral therapy to improve glycemic control in Canadian adults with type 2 diabetes.

3 Oct 2011